Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 89 peer-reviewed journal articles Updated
Neurology · Focal Cortical Dysplasia

Isolated Focal Cortical Dysplasia: A Patient Guide

At a Glance

Isolated focal cortical dysplasia is a small developmental abnormality in the brain that can trigger seizures, including seizures that resist medication. Specialized epilepsy-center evaluation helps determine whether resection or laser ablation can safely target it.

Isolated Focal Cortical Dysplasia (FCD) is a structural developmental malformation of the brain where a small group of neurons fails to follow the typical biological blueprint [1]. Instead of forming the organized layers of the cerebral cortex, these cells grow in a disorganized or abnormal fashion, creating a “focal” area of excitability that can trigger seizures [2]. Because the rest of the brain usually develops normally, these localized areas can be quite subtle, often requiring specialized, high-resolution imaging to detect [3].

For many families, the journey toward an FCD diagnosis begins as a “diagnostic odyssey” characterized by seizures that do not respond well to standard antiseizure medications [4]. While structural epilepsies can respond to antiseizure medications, drug resistance—generally defined as the failure of two appropriate, tolerated medication regimens—is a common and often frightening experience [5][6]. Reaching this diagnosis is a significant milestone, as it allows the care team to shift focus from general seizure management to targeted strategies that address the physical cause within the brain [7].

The biological root of FCD, especially Type II, often lies in the mTOR pathway, a master regulator of cell growth [8]. In many cases, a “typo” in the genetic code occurs in a single cell during early brain development [9]. Because this is frequently a somatic mutation—meaning it is present only in the affected brain tissue and not in the rest of the body—standard blood or saliva genetic tests often return “normal” results [10]. Understanding that the mutation is often confined to the brain helps explain why the condition isn’t typically inherited and why direct analysis of brain tissue is often the only way to find a definitive genetic answer, though even tissue testing can be negative, and a genetic counselor should be consulted [11].

Because of the physical nature of FCD, there has been a significant shift in how the medical community approaches treatment. Rather than enduring years of unsuccessful medication trials, current standard care emphasizes early evaluation at specialized epilepsy centers [12]. This proactive approach aims to determine if the abnormal area can be safely removed or treated through resective surgery or laser ablation [13]. The ultimate goal of this specialized care is not just to reduce seizures, but to aim for total seizure freedom, which is strongly associated with better long-term cognitive development and quality of life [14]. Finding these answers provides a roadmap for families, offering a path toward stability and hope for the future [15].

What This Guide Can and Cannot Tell You

This guide provides an overview of the medical consensus regarding isolated FCD. However, FCD diagnosis, surgical candidacy, medication tapering, and genetic recurrence risk require individualized review by a comprehensive epilepsy team. Do not make changes to your child’s care or medication based on this guide alone.

In this guide

6 chapters

01

Understanding Your Child's Diagnosis: Isolated FCD

Learn what isolated focal cortical dysplasia means for your child, how FCD-related epilepsy may present, why diagnosis can take time, and when to seek help.

02

The Biology and Genetics of FCD: Why Blood Tests Are Often Normal

Learn why blood tests can be normal in focal cortical dysplasia, how brain-only mutations affect seizures, and when tissue sequencing may help explain FCD genetics.

03

The Search for Answers: How FCD is Diagnosed

Learn how focal cortical dysplasia is diagnosed in children, from epilepsy-protocol MRI and EEG to PET, MEG, neuropsychological testing, and SEEG to guide care.

04

Decoding the Pathology Report: Subtypes of FCD

Learn to read your child’s focal cortical dysplasia pathology report, including Type I and II subtypes, balloon cells, gene tests, margins, and surgery results.

05

Treatment Strategies: From Medication to Surgery

Learn how focal cortical dysplasia is treated, including medication limits, epilepsy surgery, LITT, VNS, RNS, and ketogenic diet options for children.

06

After Surgery: Recovery and the Long-Term Outlook

Learn about recovery after focal cortical dysplasia surgery, including seizure monitoring, medication tapering, development, and what happens if seizures return.

Common questions in this guide

What is isolated focal cortical dysplasia?
Isolated focal cortical dysplasia is a developmental abnormality in which a small area of the brain’s outer layer forms abnormally. The area can become overactive and trigger seizures, while the rest of the brain often develops normally.
How is isolated FCD found on brain imaging?
The abnormal area can be very subtle, so specialized high-resolution brain imaging may be needed to detect it. The epilepsy team uses imaging and other clinical information to assess whether a structural abnormality such as FCD is present.
When should my child have an evaluation for epilepsy surgery?
If seizures continue after two appropriate, tolerated antiseizure medication regimens, this is commonly considered drug-resistant epilepsy. That is a reason to seek early evaluation at a specialized epilepsy center, but it does not mean surgery is automatically the right choice.
Why can a genetic test be negative in focal cortical dysplasia?
FCD is often caused by a change that occurs only in the affected brain tissue, called a somatic mutation. Because blood and saliva usually do not contain that change, those tests can be normal; even testing brain tissue can sometimes be negative. A genetic counselor can help explain what the results mean.
What treatments are available for isolated FCD?
Antiseizure medicines may be used to control seizures. If the abnormal area can be treated safely, a specialized epilepsy team may consider removing it with resective surgery or treating it with laser ablation. The goal is the best possible seizure control, including seizure freedom when achievable.
Could ongoing seizures affect my child’s development?
Seizures that continue over time can affect long-term cognitive development and quality of life. Achieving seizure freedom is strongly associated with better long-term outcomes, so the care team should discuss a plan if seizures persist.

Get notified when new evidence is published on Isolated focal cortical dysplasia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (15)
  1. 1

    The specific DNA methylation landscape in focal cortical dysplasia ILAE type 3D.

    Wang DD, Katoch M, Jabari S, et al.

    Acta neuropathologica communications 2023; (11(1)):129 doi:10.1186/s40478-023-01618-6.

    PMID: 37559109
  2. 2

    Focal cortical dysplasia: an update on diagnosis and treatment.

    Guerrini R, Barba C

    Expert review of neurotherapeutics 2021; (21(11)):1213-1224 doi:10.1080/14737175.2021.1915135.

    PMID: 33834938
  3. 3

    The impact of referring patients with drug-resistant focal epilepsy to an epilepsy center for presurgical diagnosis.

    Mann L, Rosenow F, Strzelczyk A, et al.

    Neurological research and practice 2023; (5(1)):65 doi:10.1186/s42466-023-00288-y.

    PMID: 38093325
  4. 4

    Outcomes of Early-Life Focal Cortical Dysplasia-Related Epilepsy: A PERC Surgery Study.

    Cohen NT, Depositario-Cabacar DF, Oluigbo CO, et al.

    Neurology. Clinical practice 2025; (15(6)):e200539 doi:10.1212/CPJ.0000000000200539.

    PMID: 41070137
  5. 5

    Challenges in managing epilepsy associated with focal cortical dysplasia in children.

    Wong-Kisiel LC, Blauwblomme T, Ho ML, et al.

    Epilepsy research 2018; (145()):1-17 doi:10.1016/j.eplepsyres.2018.05.006.

    PMID: 29803953
  6. 6

    Focal to bilateral tonic-clonic seizures predict pharmacoresistance in focal cortical dysplasia-related epilepsy.

    Chang P, Xie H, Illapani VSP, et al.

    Epilepsia 2023; (64(9)):2434-2442 doi:10.1111/epi.17700.

    PMID: 37349955
  7. 7

    Children with seizures and radiological diagnosis of focal cortical dysplasia: can drug-resistant epilepsy be predicted earlier?

    Zvi IB, Enright N, D'arco F, et al.

    Epileptic disorders : international epilepsy journal with videotape 2022; (24(1)):111-122 doi:10.1684/epd.2021.1368.

    PMID: 34750096
  8. 8

    Epilepsy in the mTORopathies: opportunities for precision medicine.

    Moloney PB, Cavalleri GL, Delanty N

    Brain communications 2021; (3(4)):fcab222 doi:10.1093/braincomms/fcab222.

    PMID: 34632383
  9. 9

    Somatic Mutations Activating the mTOR Pathway in Dorsal Telencephalic Progenitors Cause a Continuum of Cortical Dysplasias.

    D'Gama AM, Woodworth MB, Hossain AA, et al.

    Cell reports 2017; (21(13)):3754-3766 doi:10.1016/j.celrep.2017.11.106.

    PMID: 29281825
  10. 10

    Somatic mutations involving TSC 1 and TSC2 genes in two children with focal cortical dysplasia.

    Jha R, Kurup A, Kovilapu UB, et al.

    Brain & development 2022; (44(2)):166-172 doi:10.1016/j.braindev.2021.10.002.

    PMID: 34756499
  11. 11

    Somatic variant analysis of resected brain tissue in epilepsy surgery patients.

    Sanders MWCB, Koeleman BPC, Brilstra EH, et al.

    Epilepsia 2024; (65(12)):e209-e215 doi:10.1111/epi.18148.

    PMID: 39460693
  12. 12

    Prevalence and Risk Factors for Pharmacoresistance in Children With Focal Cortical Dysplasia-Related Epilepsy.

    Cohen NT, Chang P, You X, et al.

    Neurology 2022; (99(18)):e2006-e2013 doi:10.1212/WNL.0000000000201033.

    PMID: 35985831
  13. 13

    Seizure Outcome After Surgery for MRI-Diagnosed Focal Cortical Dysplasia: A Systematic Review and Meta-analysis.

    Willard A, Antonic-Baker A, Chen Z, et al.

    Neurology 2022; (98(3)):e236-e248 doi:10.1212/WNL.0000000000013066.

    PMID: 34893558
  14. 14

    Predictors of postoperative long-term seizure outcome in pediatric patients with focal cortical dysplasia type II at a German tertiary epilepsy center.

    Salemdawod A, Wach J, Banat M, et al.

    Journal of neurosurgery. Pediatrics 2022; (29(1)):83-91 doi:10.3171/2021.7.PEDS21219.

    PMID: 34653986
  15. 15

    Expedited epilepsy surgery prior to drug resistance in children: a frontier worth crossing?

    Hale AT, Chari A, Scott RC, et al.

    Brain : a journal of neurology 2022; (145(11)):3755-3762 doi:10.1093/brain/awac275.

    PMID: 35883201

This guide about isolated FCD, genetic testing, and treatment options is for informational purposes only and does not constitute medical advice. Do not change your child’s medicines or make surgical decisions without guidance from a comprehensive epilepsy team.